Please assess the completion status of the following clinical trial:

Trial Title: Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Metastatic or locally advanced gastric cancer or adenocarcinoma of the esophagogastric junction~* No prior chemotherapy in metastatic state~* Adequate blood and biochemistry parameters~Exclusion Criteria:~* Hypersensitivity for 5-FU, Leucovorin, Oxaliplatin or Docetaxel~* KHK, cardiomyopathy or cardiac insufficiency~* Malignancy \<5 years ago~* Brain metastases~* Severe internal disease or inadequate blood and biochemistry parameters~* Pregnancy and lactation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- FLOT (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).